Results 211 to 220 of about 173,452 (291)

Third‐Generation EGFR‐TKIs Combined With Chemotherapy in Advanced Non‐Small Cell Lung Cancer: A Real‐World Study

Cancer Science, EarlyView.
This study was the largest sample size of first‐line third‐generation TKIs combined chemotherapy among advanced EGFRm NSCLC patients in the real world. It was never reported that aumolertinib and furmonertinib showed comparable PFS benefits to osimertinib in combination with chemotherapy. The overall safety profile remained acceptable. ABSTRACT FLAURA2
YuQin Jiang, Qi Liang, Yuting Zhu, Xiao Liang, Ruohan Huang, Wenxin Zhou, Chen Zhang, Jun Li, Jiali Xu, Renhua Guo   +9 more
wiley   +1 more source

Creatine Kinase Elevations and Risk of Renal Failure and Dialysis in Patients With Rhabdomyolysis. [PDF]

Cureus
Jehle DV, Schultz H, Khatri R, Forks PJ, Paul KK, Reed SA, Akinwande O, Hoffmann HP, O'Connell D.   +8 more
europepmc   +1 more source

Differentiation and fiber type-specific activity of a muscle creatine kinase intronic enhancer [PDF]

, 2011
Phillip W.L. Tai, Katherine Fisher-Aylor, Charis L. Himeda, Catherine L. Smith, Alexandra P MacKenzie, Deri Helterline, John C. Angello, Robert E. Welikson, B Wold, Stephen D. Hauschka   +9 more
openalex   +1 more source

High Concordance of Copy Number Variants Detected by Chromosomal Microarray and Exome Sequencing in Clinical Diagnostics

Clinical Genetics, EarlyView.
To assess the relevance of exome sequencing as a first‐tier diagnostic tool, three aspects were investigated: detection of copy number variants (CNVs) from exomes as compared to chromosomal microarray, clinically‐relevant CNVs across all sizes, and additional diagnostic utilities (uniparental disomy and triploidy).
Rivka Birnbaum, Maya Slovik, Shamir Zenvirt, Ilana Livyatan, Israel Altman, Shiri Gershon, Jonathan Rips, Hagit Daum, Chaggai Rosenbluh, Orly Elpeleg, Vardiella Meiner, Ayala Frumkin, Hagar Mor‐Shaked, Tamar Harel   +13 more
wiley   +1 more source

Isotretinoin-Associated Myopathy With Normal Creatine Kinase (CK) Levels: EMG-Based Diagnosis at Low Dose-A Case Report. [PDF]

Clin Case Rep
Mahyar M, Jahanbazi R, Khorram A, Shahramirad S, Vataniman M.   +4 more
europepmc   +1 more source

Microscopic and molecular aspects of skeletal muscle alterations in cerebral palsy

Developmental Medicine &Child Neurology, EarlyView.
Cerebral palsy, caused by non‐progressive brain injury, is frequently accompanied by skeletal muscle alterations. This review synthesizes current evidence from muscle biopsy studies, revealing cellular and molecular adaptations in muscle tissue. Abstract Cerebral palsy (CP), the most prevalent childhood‐onset motor disability, frequently entails ...
Sebastian Edman, Oscar Horwath, Eva Pontén, Sudarshan Dayanidhi, Ferdinand von Walden   +4 more
wiley   +1 more source

Creatine kinase B, a downstream effector of c-Myb, controls migration of osteosarcoma cells via regulation of N-cadherin. [PDF]

Cancer Cell Int
Pokludová J, Lapčík P, Zambo IS, Kohoutek J, Zapletalová D, Múdry P, Adámková D, Červinka J, Loja T, Lexa M, Verner J, Šmarda J, Bouchal P, Knopfová L, Beneš P.   +14 more
europepmc   +1 more source

Clinical role of recurrently elevated macro creatine kinase type 1 [PDF]

, 2008
Ju‐Feng Hsiao, Hsiao‐Chen Ning, Po‐Wen Gu, Wei‐Yee Lin, Pao‐Hsien Chu   +4 more
openalex   +1 more source

Diabetic kidney disease, biomarkers, and finerenone

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Diabetic kidney disease (DKD), the leading cause of kidney failure worldwide, is associated with an increased risk of cardiovascular disease (CVD). A complex pathobiology involving hemodynamic, metabolic, and immune dysregulation promotes inflammatory and fibrotic pathways that contribute to kidney disease progression and CVD in individuals ...
Ashish Verma, Ashish Upadhyay
wiley   +1 more source

Creatine kinase and its muscle/brain isoenzyme as potential biomarkers for cardiovascular disease risk: A cross-sectional analysis of a population-based cohort. [PDF]

PLoS One
Izadpanah M, Pourahmadi E, Bana HS, Dehghani E, Akbari M, Rezae FA, Yarmohammadi F, Alnattah A, Eslami S, Taherzadeh Z.   +9 more
europepmc   +1 more source